Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: allergy  medications  health  sanofi  relief  medical  adam  savage  treatment  multivu  8255452  sanofi  vaccines  health  treatment  fluzone  flu  fda  medical  healthcare  multivu  8081151  allergy  education  healthcare  safety  retail  xyzal  relief  medical  drugs  multivu  8029451  flu  vaccine  health  healthcare  fluzone  fda  pharmacies  sanofi  medical  multivu  7842051  sanofi  osteoarthritis  rodillas  sin  dolor  viscosuplementacion  cuidado  salud  multivu  7099651  nasacort  allergy  24hr  nasal  spray  nancy  lieberman  womens  basketball  over  the  counter  medicine  multivu  7122351  sanofi  pasteur  clostridium  difficile  infection  vaccine  bacteria  cdiffense  health  study  multivu  62652  voices  meningitis  prevention  public  health  nasn  sanofi  meningococcal  disease  teen  vaccination  healthcare  multivu  61652  sounds  pertussis  baby  health  whooping  cough  sarah  michelle  gellar  sanofi  adult  vaccination  infant  children  multivu  61367  auvi-q  sanofi  anaphylaxis  jerome  bettis  allergies  allergic  reaction  epinephrine  injection  health  multivu  59439  sanofi  diabetes  co-stars  elizabeth  perkins  type  1  treatment  casting  call  support  health  multivu  57457  sanofi  regeneron  pcsk9  antibody  ldl  bad  cholesterol  heart  disease  statins  medication  healthcare  multivu  55299 
Search // sanofi
Results 1-12 of 14 for ' sanofi ' (0 seconds)
Every spring, allergies take control of the lives of millions of Americans, affecting their work, their family time and even how well they sleep at night. Something else affects those millions of allergy sufferers, according to a new survey: big misconceptions about allergies that may keep people from getting needed relief. To help put those misconceptions about allergies to rest, Sanofi is teaming up with science educator and television personality Adam Savage, along with allergist Dr. Neeta Ogden, to dispel them with credible information. The goal: help the 50 million allergy sufferers in America get the facts they need to understand and treat their allergies and take back control of their lives. To view the multimedia release go to: https://www.multivu.com/players/English/8255452-sanofi-allergy-misconceptions-facts-adam-savage/
Categories // Miscellaneous 
Added: 60 days ago by MultiVuVideos
Runtime: 1m4s | Views: 8 | Comments: 2
Not yet rated
 

 

 

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns. “As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.” To view the multimedia release go to: https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
Categories // Miscellaneous 
Added: 312 days ago by MultiVuVideos
Runtime: 1m27s | Views: 6 | Comments: 0
Not yet rated
 

 

 

Sanofi Consumer Healthcare – the makers of new Xyzal® Allergy 24HR, which is now available on retail shelves nationwide – revealed today the results of a social experiment in which 160 participants (80 allergy sufferers and 80 non-sufferers) wore a wearable device for 30 days to track their sleep and activity. The first-of-its-kind experiment found allergy symptoms can impact various elements of sufferers’ lives, including both the quality of their sleep and their daytime activities. Xyzal is partnering with renowned allergist Dr. Neeta Ogden to encourage allergy sufferers to Wise Up about the importance of managing their allergies this spring, so they can have a better night’s sleep and Rise Up in the morning to take on the day. To view the multimedia release go to: https://www.multivu.com/players/English/8029451-sanofi-xyzal-allergy-social-experiment-wise-up-rise-up/
Categories // Miscellaneous 
Added: 431 days ago by MultiVuVideos
Runtime: 1m4s | Views: 6 | Comments: 0
Not yet rated
 

 

 

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of Fluzone® (Influenza Vaccine) for the 2016-2017 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA) for shipment. This represents the first of more than 65 million total doses of seasonal influenza vaccine manufactured by Sanofi Pasteur that will be delivered to U.S. health care providers and pharmacies beginning in July and continuing throughout the remainder of the year. Sanofi Pasteur plans to increase its supply to respond to the shifting pediatric public health needs. Seasonal influenza activity typically occurs between October and May and peaks between December and February. However, influenza activity peaked noticeably late last season occurring in early March 2016.1 Influenza seasons are always unpredictable as new influenza strains emerge and strain activity fluctuates throughout the year, making timely vaccination even more important to help protect against the virus, especially for seniors, young children and infants six months of age and older. To view the multimedia release go to: http://www.multivu.com/players/English/7842051-sanofi-pasteur-influenza-vaccine/
Categories // Miscellaneous 
Added: 669 days ago by MultiVuVideos
Runtime: 4m50s | Views: 176 | Comments: 0
Not yet rated
 

 

 

La osteoartritis (OA) es una de las primeras 10 causas de invalidez total en México, lo que incrementa la carga económica y social del país, siendo las rodillas una de las articulaciones más frecuentemente afectadas por esta enfermedad, con una prevalencia de 10% en hombres y 13% en mujeres de 60 años de edad1. Especialistas en la materia, indican que es muy importante crear conciencia sobre el cuidado de estas articulaciones desde edades tempranas. Con este objetivo y para generar un mayor conocimiento de este padecimiento, se desarrolló la campaña “Rodillas sin dolor”. Para ver los activos de multimedia asociados con este comunicado, haga clic en: http://www.multivu.com/players/English/7099651-sanofi-rodillas-sin-dolor-lesiones-tempranas-osteoartritis/
Categories // People and Blog 
Added: 1318 days ago by MultiVuVideos
Runtime: 1m30s | Views: 305 | Comments: 1
Not yet rated
 

 

 

Nancy Lieberman, basketball hall of famer, coach and mom, has teamed up with Sanofi’s consumer healthcare division Chattem Inc. to introduce a new, more effective player on the over-the-counter (OTC) allergy medication roster, Nasacort Allergy 24HR Nasal Spray. Now available in stores nationwide, Nasacort Allergy 24HR is different than other currently available OTC allergy medications. It puts the “Full ‘Cort Press” on the full range of nasal allergy symptoms for 24 hours with a once daily dose. Nasacort Allergy 24HR is the first and only medicine in its class to be available at full prescription strength without the need for a prescription. To view the Multimedia News Release, go to http://www.multivu.com/mnr/7122351-basketball-hall-of-famer-nancy-lieberman-nasacort-allergy-24hr
Categories // Business 
Added: 1500 days ago by MultiVuVideos
Runtime: 0m56s | Views: 585 | Comments: 0
Not yet rated
 

 

 

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwide. To view the Multimedia News Release, go to http://www.multivu.com/mnr/62652-sanofi-pasteur-initiates-phase-iii-study-of-investigational-vaccine
Categories // Business  Science and Technology 
Added: 1755 days ago by MultiVuVideos
Runtime: 1m59s | Views: 1046 | Comments: 0
Not yet rated
 

 

 

Voices of Meningitis, a public health initiative of the National Association of School Nurses (NASN) in collaboration with Sanofi Pasteur, announced today the launch of Get in the Game: Keeping Teens Healthy, a new program to help educate parents on the danger and prevention of meningococcal disease. Get in the Game will help raise awareness about the serious consequences of the disease and motivate parents to speak with their children's health care professional about vaccinating against meningococcal disease in advance of each sports season. To view Multimedia News Release, go to http://www.multivu.com/players/English/61652-voices-of-meningitis-get-in-the-game/
Categories // People and Blog 
Added: 1807 days ago by MultiVuVideos
Runtime: 2m16s | Views: 1236 | Comments: 0
Not yet rated
 

 

 

Actress and mother of two Sarah Michelle Gellar is joining March of Dimes and Sanofi Pasteur on the Sounds of Pertussis® Campaign to help raise awareness about pertussis, also known as whooping cough, and the importance of adult vaccination. Pertussis is on the rise across the U.S., and infants and young children may be most vulnerable. To view Multimedia News Release, go to http://www.multivu.com/players/English/61367-sanofi-pasteur-sounds-of-pertussis/
Categories // Family  People and Blog 
Added: 1816 days ago by MultiVuVideos
Runtime: 2m19s | Views: 1471 | Comments: 0
Not yet rated
 

 

 

Jerome Bettis and Robin Miller are teaming up with Sanofi US to raise awareness of life-threatening allergic reactions (anaphylaxis) and spread the word that Auvi-Q™ (epinephrine injection, USP) is now available by prescription in pharmacies nationwide. Bettis, who is allergic to shellfish, and Miller, who is allergic to eggs, hope to help educate adults and caregivers of children at risk for severe allergic reactions. Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. The size and shape of a credit card and the thickness of a smart phone, Auvi-Q is a breakthrough in epinephrine auto-injector design that talks patients and caregivers step-by-step through the injection process. To view Multimedia News Release, go to http://www.multivu.com/mnr/59439-auvi-q-epinephrine-injection-usp-now-available-by-prescription-in-u-s
Added: 1942 days ago by MultiVuVideos
Runtime: 3m27s | Views: 1679 | Comments: 0
Not yet rated
 

 

 

Golden Globe and Emmy nominated actress Elizabeth Perkins, who is living with type 1 diabetes, is partnering with Sanofi US on the Diabetes Co-Stars awareness campaign to produce a new documentary that will feature people living with diabetes and those who support them. Beginning today through December 16, 2012, people can submit their stories to the nationwide casting call at www.DiabetesCoStars.com. To view Multimedia News Release, go to https://www.multivu.com/mnr/57457-sanofi-us-elizabeth-perkins-casting-call-diabetes-co-stars-documentary
Categories // People and Blog 
Added: 2018 days ago by MultiVuVideos
Runtime: 1m33s | Views: 3013 | Comments: 0
Not yet rated
 

 

 

Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from two Phase 2 trials with SAR236553/REGN727, an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), were presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Meeting in Chicago. The data showed that treatment with SAR236553/REGN727 over 8 to 12 weeks significantly reduced mean low-density lipoprotein-cholesterol (LDL-C, or “bad” cholesterol) by 40% to 72% in patients with elevated LDL-C on stable dose of statins. To view Multimedia News Release, go to http://www.multivu.com/mnr/55299-sanofi-regeneron-pharmaceuticals-lipid-lowering-medications-pcsk9-antibody
Added: 2252 days ago by MultiVuVideo
Runtime: 3m19s | Views: 3872 | Comments: 0
Not yet rated
 

 

 

Page 1 of 2  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2018 ClipMoon.com. All rights reserved.